Bioheaven 360

Delhi, India Founded: 2018 • Age: 8 yrs Minicorn
AI-powered genomics tools for disease risk prediction are provided.

About Bioheaven 360

Bioheaven 360 is a Healthcare company based in Delhi (India) founded in 2018. AI-powered genomics tools for disease risk prediction are provided. Bioheaven 360 has raised $264.39 thousand across 3 funding rounds from investors including Digital Futurists Angels, Christudas Philipose Anchuturuthen and Hiren Thakkar. Bioheaven 360 was last valued at $1.44 million in June 2022. Its Indian entity Bioheaven 360 Genotec Private Limited reported revenue of β‚Ή1.86 Cr. Bioheaven 360 offers products and services including Biologicals, Biosimilars, AI-based Intel Generation, and Cell Therapies. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.

Company details

Bioheaven 360 was established in 2018 in Delhi, India, within the biotechnology sector. AI and machine learning models for patient classification are utilized in clinical environments to enable early detection of osteoporosis. Genomics-based diagnostics tools are offered for disease risk prediction, supporting healthcare applications focused on preventive classification and assessment.

Key Metrics
  • Annual Revenue
    ₹1.86 Cr

    FY 2024 · +79% YoY

  • Net Profit
    ₹1 Lakh

    FY 2024 · 1% margin

  • EBITDA
    ₹14 Lakh

    FY 2024 · 8% margin

  • Total Equity Funding
    $264.39K (USD)

    in 3 rounds

  • Latest Funding Round
    $122.9K (USD), Seed

    Jan 2023

  • Investors

Products & Services of Bioheaven 360

Bioheaven 360 offers a comprehensive portfolio of products and services, including Biologicals, Biosimilars, AI-based Intel Generation, and Cell Therapies.

Biologicals
Healthcare Products

Products for immunology, cell therapies, and biosimilars development.

Biosimilars
Biopharmaceuticals

Alternatives to biological medicines for disease treatment.

AI-based Intel Generation
Data Services

AI solutions for industry-specific biological data integration.

Cell Therapies
Regenerative Medicine

Treatments using stem cells for regeneration and health improvement.

Funding Insights of Bioheaven 360

Bioheaven 360 has successfully raised a total of $264.39K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $122.9 thousand completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $264,389
  • Total Rounds 3
  • Last Round Seed β€” $122,903
  • First Round $27,196

    (May 2021)

  • Investors Count 38

All 3 funding rounds of Bioheaven 360 with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2023$122,903Seed–Digital Futurists Angels
–
Jun 2022$114,290Angel Round$1.44MChristudas Philipose Anchuturuthen, Hiren Thakkar
–
May 2021$27,196Angel Round$1.65MSanjay Nagi, Deepika Gupta Sachdev
–
Valuation history
DateValuationStage
Jun 2022$1.44Mβ€’β€’β€’β€’β€’β€’β€’β€’
May 2021$1.65Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $1.44M (Jun 2022). 38 investors in total: 1 institutional and 37 angel.

Investors in Bioheaven 360

Bioheaven 360 has secured backing from 38 investors, including venture fund and angel investors. Prominent investors backing the company include Digital Futurists Angels, Christudas Philipose Anchuturuthen and Hiren Thakkar.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Provider of technology consulting and focused on multiple sectors
2020dfangels.inGurugram, India

Christudas Philipose Anchuturuthen

unknown_d3c361fca1ff442ea

Hiren Thakkar

Angel investor and entrepreneur, focused on tech startups in India.
unknown_747f2d114e354d31a

Sachin Seth

unknown_6401eac6be6f43b39

Jigar Shah

unknown_bf3b0f84799b4c7c8

Sandeep Kumar Arora

unknown_93c8403b22eb48f79

Shashi Shekhar Mishra

unknown_9a1801be58d5402ab

Tushar D Waghulde

unknown_b950e8287e1e4ecdb

Rahul Yadav

Founder of Housing.com, angel investor in Indian startups
unknown_9c013dcf76cf404ab

Aftab Shamsuddin Mohd

unknown_64e1f473d36148b09
Premium access

Investor details for Bioheaven 360

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Bioheaven 360 Genotec Private Limited (Bioheaven 360)

Bioheaven 360 Genotec Private Limited is the primary company behind Bioheaven 360. The board of Bioheaven 360 Genotec Private Limited currently have 3 directors; the longest-serving is Shailendra Vyas, appointed in 2018. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Shailendra Vyas
DIN 08097485
Director27 Mar 20188 yrs 7 moBioheaven 360 Genotec Private Limited
Suman Kumari
DIN 08097486
Director27 Mar 20188 yrs 7 moBioheaven 360 Genotec Private Limited
Sanjay Nagi
DIN 05289153
Director24 Jul 20206 yrs 3 moBioheaven 360 Genotec Private Limited

Financials of Bioheaven 360

Figures of Bioheaven 360 Genotec Private Limited, the primary company behind Bioheaven 360, for FY 2024. Revenue was ₹1.86 Cr (+79% year on year). Net profit was ₹1 Lakh (1% margin). EBITDA was ₹14 Lakh (8% margin). Revenue has grown at a compounded annual rate of +91% over three years and +47% over five years.

  • ₹1.86 CrRevenue · FY 2024 · +79% YoY
  • ₹1 LakhNet profit · 1% margin
  • ₹14 LakhEBITDA · 8% margin
  • ₹1.1 LakhPaid-up capital
  • +91%Revenue CAGR, 3 years
  • +47%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bioheaven 360 Genotec Private Limited are on its company page.

Premium access

Detailed financial statements for Bioheaven 360

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Bioheaven 360

4 dated milestones of Bioheaven 360 across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bioheaven 360 is founded.
  2. Funding First funding round of $27K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Seed, of $123K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bioheaven 360

Bioheaven 360 was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Bioheaven 360 is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Bioheaven 360 is a funded company, having raised a total of $264.39K across 3 funding rounds to date. The company's 1st funding round was a Angel Round of $27.2K, raised on May 2021.

The primary company behind Bioheaven 360, Bioheaven 360 Genotec Private Limited, reported revenue of β‚Ή1.86 Cr for FY 2024, up 79% year on year.

Bioheaven 360 was established in 2018 in Delhi, India, within the biotechnology sector. AI and machine learning models for patient classification are utilized in clinical environments to enable early detection of osteoporosis. Genomics-based diagnostics tools are offered for disease risk prediction, supporting healthcare applications focused on preventive classification and assessment.

Bioheaven 360 offers Biologicals, Biosimilars, AI-based Intel Generation, and Cell Therapies.

Bioheaven 360 has 38 investors. Key investors include Digital Futurists Angels, Christudas Philipose Anchuturuthen, Hiren Thakkar, Sachin Seth, and Jigar Shah.

The valuation of Bioheaven 360 is $1.44M as of Jun 2022.

Bioheaven 360 operates through Bioheaven 360 Genotec Private Limited.

The legal entities of Bioheaven 360 currently have 3 directors, including Shailendra Vyas, Sanjay Nagi, Suman Kumari.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available